Article Information
History
- April 12, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Brian D. Quinlan1,7,
- Huihui Mou1,7,
- Lizhou Zhang1,7,
- Yan Guo1,7,
- Wenhui He1,
- Amrita Ojha1,
- Mark S. Parcells2,
- Guangxiang Luo3,
- Wenhui Li4,
- Guocai Zhong5,6,
- Hyeryun Choe1,* and
- Michael Farzan1,*
- 1Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL 33458, USA
- 2Department of Animal and Food Sciences, University of Delaware, Newark, DE 19716, USA
- 3Department of Microbiology, University of Alabama at Birmingham School Of Medicine, Birmingham, AL 35294, USA
- 4National Institute of Biological Sciences, Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing, China
- 5Scripps Research | SZBL Chemical Biology Institute, Shenzhen Bay Laboratory (SZBL), Shenzhen, China
- 6School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
- ↵*Correspondence: hchoe{at}scripps.edu (H.C.); mfarzan{at}scripps.edu (M.F.)
↵7 These authors contributed equally
Posted April 12, 2020.
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
